Assyro AI

Orange Book product · Brand (NDA)

POTASSIUM PHOSPHATES

POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC

Brand (NDA)NDA 212121DISCN CMP DEV LLC

At a glance

Sep 19, 2019

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Sep 19, 2019

    6 yr 10 mo ago

  2. Today

  3. Patent 10632150 expires

    Listed drug product patent expiration.

    Apr 19, 2039

    in 13 yr

Pharmaceutical detail

Active ingredient

POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC

Strength

4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML)

Dosage form

SOLUTION

Route

INTRAVENOUS

TE code

Not listed

Application

NDA 212121

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
10632150Apr 19, 2039in 13 yr
ProductU-2789
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.